BEAVERTON, Ore.--(BUSINESS WIRE)--USB Implementers Forum (USB-IF), the support organization for the advancement and adoption of USB technology, today announced the launch of its USB Type-C™ ...

(RTTNews) - Revvity, Inc. (RVTY), a health science solution provider, on Thursday announced a program for its Type 1 diabetes service, with support from Pharma major Sanofi (SNY). The program includes ...

Designing a language immersion program requires a level of commitment on the part of the administration, teachers, students, and parents that is far beyond that of many other types of instructional ...

Type 2 diabetes affects approximately 8 percent of adults in the United States. Some risk factors — elevated plasma glucose concentrations in the fasting state and after an oral glucose load, ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Marguerita is a Certified Financial Planner (CFP), Chartered Retirement Planning Counselor ...

- VX-264 Phase 1/2 enrollment and dosing complete in Parts A and B: VX-264 was generally safe and well tolerated; efficacy data are not supportive of further clinical advancement - - Zimislecel ...